- Home
- NUWE vs BME Comparison
NUWE vs BME Comparison
Compare NUWE & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUWE
- BME
- Stock Information
- Founded
- NUWE 1999
- BME 2005
- Country
- NUWE United States
- BME United States
- Employees
- NUWE N/A
- BME N/A
- Industry
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- BME Trusts Except Educational Religious and Charitable
- Sector
- NUWE Health Care
- BME Finance
- Exchange
- NUWE Nasdaq
- BME Nasdaq
- Market Cap
- NUWE 3.9M
- BME 486.1M
- IPO Year
- NUWE N/A
- BME N/A
- Fundamental
- Price
- NUWE $3.24
- BME $38.30
- Analyst Decision
- NUWE
- BME
- Analyst Count
- NUWE 0
- BME 0
- Target Price
- NUWE N/A
- BME N/A
- AVG Volume (30 Days)
- NUWE 157.1K
- BME 34.0K
- Earning Date
- NUWE 11-12-2025
- BME 01-01-0001
- Dividend Yield
- NUWE N/A
- BME 6.26%
- EPS Growth
- NUWE N/A
- BME N/A
- EPS
- NUWE N/A
- BME 1.44
- Revenue
- NUWE $8,318,000.00
- BME N/A
- Revenue This Year
- NUWE $6.53
- BME N/A
- Revenue Next Year
- NUWE $51.63
- BME N/A
- P/E Ratio
- NUWE N/A
- BME $28.37
- Revenue Growth
- NUWE N/A
- BME N/A
- 52 Week Low
- NUWE $2.93
- BME $35.53
- 52 Week High
- NUWE $175.98
- BME $43.20
- Technical
- Relative Strength Index (RSI)
- NUWE 38.01
- BME 65.81
- Support Level
- NUWE $2.93
- BME $37.37
- Resistance Level
- NUWE $3.49
- BME $38.32
- Average True Range (ATR)
- NUWE 0.19
- BME 0.42
- MACD
- NUWE 0.02
- BME 0.04
- Stochastic Oscillator
- NUWE 33.33
- BME 86.92
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.